76 related articles for article (PubMed ID: 30077924)
1. Isolation of recombinant human antithrombin isoforms by Cellufine Sulfate affinity chromatography.
Sugihara T; Fujiwara S; Ishioka S; Urakubo T; Suzawa T
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Sep; 1095():198-203. PubMed ID: 30077924
[TBL] [Abstract][Full Text] [Related]
2. Purification and characterization of recombinant human antithrombin containing the prelatent form in Chinese hamster ovary cells.
Mochizuki S; Miyano K; Kondo M; Hirose M; Masaki A; Ohi H
Protein Expr Purif; 2005 Jun; 41(2):323-31. PubMed ID: 15866718
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human antithrombin expressed in Chinese hamster ovary cells shows in vivo efficacy on rat DIC model similarly to plasma-derived antithrombin regardless of different N-glycosylation.
Hirose M; Tsukada M; Hirayama F; Kubo Y; Kajii M; Mochizuki S; Hamato N; Ohi H
Thromb Res; 2007; 119(5):631-41. PubMed ID: 16844203
[TBL] [Abstract][Full Text] [Related]
4. Decreased affinity of recombinant antithrombin for heparin due to increased glycosylation.
Björk I; Ylinenjärvi K; Olson ST; Hermentin P; Conradt HS; Zettlmeissl G
Biochem J; 1992 Sep; 286 ( Pt 3)(Pt 3):793-800. PubMed ID: 1417738
[TBL] [Abstract][Full Text] [Related]
5. Separation between the alpha and beta forms of human antithrombin by hydroxyapatite high-performance liquid chromatography.
Karlsson G; Winge S
Protein Expr Purif; 2003 Mar; 28(1):196-201. PubMed ID: 12651125
[TBL] [Abstract][Full Text] [Related]
6. Separation of native and latent forms of human antithrombin by hydrophobic interaction high-performance liquid chromatography.
Karlsson G; Winge S
Protein Expr Purif; 2001 Feb; 21(1):149-55. PubMed ID: 11162400
[TBL] [Abstract][Full Text] [Related]
7. Separation of latent, prelatent, and native forms of human antithrombin by heparin affinity high-performance liquid chromatography.
Karlsson G; Winge S
Protein Expr Purif; 2004 Feb; 33(2):339-45. PubMed ID: 14711523
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the structure of antithrombin-binding heparan sulfate generated by heparan sulfate 3-O-sulfotransferase 5.
Chen J; Liu J
Biochim Biophys Acta; 2005 Sep; 1725(2):190-200. PubMed ID: 16099108
[TBL] [Abstract][Full Text] [Related]
9. Pasteurization of antithrombin without generation of the prelatent form of antithrombin.
Karlsson G
Protein Expr Purif; 2004 Jun; 35(2):381-6. PubMed ID: 15135417
[TBL] [Abstract][Full Text] [Related]
10. Carbohydrate isoforms of antithrombin variant N135Q with different heparin affinities.
Turko IV; Fan B; Gettins PG
FEBS Lett; 1993 Nov; 335(1):9-12. PubMed ID: 8243674
[TBL] [Abstract][Full Text] [Related]
11. A Comparison of the Oligosaccharide Structures of Antithrombin Derived from Plasma and Recombinant Using POTELLIGENT
Yagi Y; Okazaki A; Endo M; Yanagisawa K; Fukuda J; Nishimura K; Yamazaki K
Anal Sci; 2019 Dec; 35(12):1333-1340. PubMed ID: 31423004
[TBL] [Abstract][Full Text] [Related]
12. Characterization of recombinant human antithrombin III synthesized in Chinese hamster ovary cells.
Zettlmeissl G; Conradt HS; Nimtz M; Karges HE
J Biol Chem; 1989 Dec; 264(35):21153-9. PubMed ID: 2592368
[TBL] [Abstract][Full Text] [Related]
13. Heparin cofactor II determination--levels in normals and patients with hereditary antithrombin III deficiency and disseminated intravascular coagulation.
Tran TH; Duckert F
Thromb Haemost; 1984 Oct; 52(2):112-6. PubMed ID: 6395434
[TBL] [Abstract][Full Text] [Related]
14. Effect of individual carbohydrate chains of recombinant antithrombin on heparin affinity and on the generation of glycoforms differing in heparin affinity.
Olson ST; Frances-Chmura AM; Swanson R; Björk I; Zettlmeissl G
Arch Biochem Biophys; 1997 May; 341(2):212-21. PubMed ID: 9169007
[TBL] [Abstract][Full Text] [Related]
15. Separation of active and inactive forms of recombinant human plasminogen activator inhibitor type 1 (PAI-1) expressed in Chinese hamster ovary cells: comparison with native human PAI-1.
Strömqvist M; Andersson JO; Boström S; Deinum J; Ehnebom J; Enquist K; Johansson T; Hansson L
Protein Expr Purif; 1994 Aug; 5(4):309-16. PubMed ID: 7950376
[TBL] [Abstract][Full Text] [Related]
16. Intermediate purification of CHO-derived recombinant human Factor IX using hydrophobic interaction membrane-based chromatography and its comparison to a sulfated resin.
Ribeiro DA; Passos DF; Ferraz HC; Castilho LR
Electrophoresis; 2017 Nov; 38(22-23):2900-2908. PubMed ID: 28869668
[TBL] [Abstract][Full Text] [Related]
17. Preparative conversion of native human antithrombin to the latent form.
Karlsson G; Winge S
Protein Expr Purif; 2002 Oct; 26(1):106-10. PubMed ID: 12356477
[TBL] [Abstract][Full Text] [Related]
18. Anticoagulant effect of unfractionated heparin in antithrombin-depleted plasma in vitro.
Krulder JW; Strebus AF; Meinders AE; Briët E
Haemostasis; 1996; 26(2):85-9. PubMed ID: 9119287
[TBL] [Abstract][Full Text] [Related]
19. Purification and characterization of recombinant human thyrotropin (TSH) isoforms produced by Chinese hamster ovary cells: the role of sialylation and sulfation in TSH bioactivity.
Szkudlinski MW; Thotakura NR; Bucci I; Joshi LR; Tsai A; East-Palmer J; Shiloach J; Weintraub BD
Endocrinology; 1993 Oct; 133(4):1490-503. PubMed ID: 8404588
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and characterisation of magnetised Dacron-heparin composite employed for antithrombin affinity purification.
Mercês AA; Silva RS; Silva KJ; Maciel JD; Oliveira GB; Buitrago DM; de Aguiar JA; de Carvalho-Júnior LB
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Dec; 1038():73-79. PubMed ID: 27810279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
